StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51−0.01 (-1.56%)

Close on Nov 18, 2026Market cap $14.02MP/E –Yield –

Citius Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Citius Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2022 was -37378.5%. For fiscal 2022 it was -37378.5%, against -25616.0% the year before. The highest annual figure on record is -16715.5% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Sep 30, 2022-37378.5%−11762.5
FY2021Sep 30, 2021-25616.0%−6118.2
FY2020Sep 30, 2020-19497.9%−2206.6
FY2019Sep 30, 2019-17291.3%−575.8
FY2018Sep 30, 2018-16715.5%+4054.4
FY2017Sep 30, 2017-20769.9%–

More Citius Pharmaceuticals figures

See a number that looks wrong?